The Rosamund Stone Zander Translational Neuroscience Center strives to improve the lives of all children with brain disorders by fostering timely and efficient translational research.
Our Advocacy and Research Partners
For Patients
Research Services
Research Funding
Featured News & Events
MED13L Foundation to Launch Natural History Study of MED13L Syndrome with Boston Children's Hospital
The MED13L Foundation today announced a nearly $250,000 grant to help launch an innovative natural history study at Boston Children’s Hospital’s Rosamund Stone Zander Translational Neuroscience Center (RSZ TNC). The MED13L Syndrome Investigation of Natural History and Development (MIND Study) is a three-year research initiative designed to build on existing data and accelerate clinical trial readiness for the MED13L Syndrome community.
IDEFINE commits $300,000 to launch natural history study of Kleefstra Syndrome with Boston Children's Hospital
IDefine – The Kleefstra Syndrome Foundation today announced a $300,000 grant to help launch a groundbreaking natural history study at Boston Children’s Hospital’s Rosamund Stone Zander Translational Neuroscience Center (RSZ TNC). The three-year study will advance critical research and help prepare the Kleefstra syndrome (KS) community for future clinical trials.
Harnessing the potential of human induced pluripotent stem cells, functional assays and machine learning for neurodevelopmental disorders
In this review, RSZ TNC researchers compare two-dimensional and three-dimensional human-induced pluripotent stem cell (hiPSC) formats for disease modeling, discuss the applications of functional assays, and offer insights on incorporating machine learning into hiPSC-based neurodevelopmental disorder research and drug screening.